Pure Biologics Spólka Akcyjna (PUR) — Working Capital to Net Assets Ratio
Pure Biologics Spólka Akcyjna (PUR) has a Working Capital to Net Assets ratio of 100.1% as of September 2025. Working capital of zł-19.40 Million (current assets of zł1.32 Million minus current liabilities of zł20.72 Million) is measured against net assets of zł-19.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Pure Biologics Spólka Akcyjna (PUR) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Pure Biologics Spólka Akcyjna Working Capital to Net Assets (2016–2024)
This chart shows how Pure Biologics Spólka Akcyjna's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 100.1%, reflecting working capital of zł-19.40 Million against net assets of zł-19.39 Million PLN. For the complete balance sheet picture, see Pure Biologics Spólka Akcyjna total assets.
Annual Working Capital to Net Assets for Pure Biologics Spólka Akcyjna (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Pure Biologics Spólka Akcyjna from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Pure Biologics Spólka Akcyjna to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (PLN) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 101.8% | zł-13.35 Million | zł-13.12 Million | zł2.11 Million | zł15.46 Million | ▼ -617.0 pp |
| 2023 | 718.8% | zł13.61 Million | zł1.89 Million | zł21.60 Million | zł7.99 Million | ▲ +656.8 pp |
| 2022 | 62.0% | zł11.34 Million | zł18.30 Million | zł24.17 Million | zł12.83 Million | ▼ -32.9 pp |
| 2021 | 94.9% | zł37.47 Million | zł39.49 Million | zł43.02 Million | zł5.55 Million | ▼ -77.0 pp |
| 2020 | 171.9% | zł-4.96 Million | zł-2.89 Million | zł13.04 Million | zł18.00 Million | ▲ +80.8 pp |
| 2019 | 91.1% | zł6.57 Million | zł7.21 Million | zł18.60 Million | zł12.03 Million | ▲ +9.4 pp |
| 2018 | 81.7% | zł1.81 Million | zł2.22 Million | zł5.73 Million | zł3.91 Million | ▲ +123.4 pp |
| 2017 | -41.7% | zł-87.55K | zł209.77K | zł1.03 Million | zł1.12 Million | ▲ +2.5 pp |
| 2016 | -44.2% | zł-137.74K | zł311.70K | zł502.39K | zł640.12K | — |